Immunotherapy in Oncology Startup Identification
ページ情報: 英文 280+ Slides
What are the startups that have emerged in Onco-Immunotherapy? What are they working on? Who are the key people in these companies?
Cancer Immunotherapy is a very dynamic technological field and the global market is expected to grow and reach US$ 126.9 billion by 2026, with a CAGR of 9.6% from 2019 to 2026 (Grand View Research). With an increasing number of people with cancer (17 million of new cases of cancer worldwide) and the need of new treatments, the immunotherapy domain sees the arrival of numerous startups every year. In this highly diverse and rapidly changing ecosystem, it is crucial to identify new players and monitor their activities to determine opportunities, threats, potential partnerships and collaborations. Because of their small size and technological diversity, these young companies are hard to identify by conventional approaches (web searches, workshops etc.). In this report, Knowmade has therefore investigated Onco-Immunotherapy-related patents in order to identify startups through their patent filings. More than 110 startups incorporated between 2010 and 2019 were thus identified, and for over 50 of them, the report describes their main activity, products, patents, and key people among their staff. This study reveals that Cell Adoptive Transfer (e.g. CAR-T cell) is by far the technology explored the most by startups working in the field of immunotherapy in oncology. Immune checkpoint inhibitor/modulator, bispecific antibody and vaccine are also technologies of interest for some startups identified.
Startups have been identified by screening the patent documents published in 2019/2020 claiming Immunotherapy in Oncology. For each startup identified, the report provides a complete description of its activity and pipeline, with a link for ongoing clinical trials. Information about funding rounds and subsidies are also described.
This report includes a detailed description of all the patents filed by identified startups. The elements provided in each overview slide provide essential information to quickly understand the patented technology. For each patent family described, the publication number of Granted/Registered and Pending members are provided, as well as the abstract, the first claim, relevant information about the invention and the most relevant figure explaining how the invention can be carried out.
This report includes a description of the key people and/or inventors involved in each selected startup. Knowing the key people behind a startup helps assessing its chances of success by determining their individual strength and their complementarity. This report is focused on the description of the people who have a technical background. For each key person, the report shows a summary of their educational background, employment history, as well as their other current activities and a link to their LinkedIn profiles.